9-98837081-G-A
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PP3_Strong
The NM_024642.5(GALNT12):c.1145G>A(p.Arg382His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000254 in 1,614,062 control chromosomes in the GnomAD database, with no homozygous occurrence. There is a variant allele frequency bias in the population database for this variant (GnomAd4), which may indicate mosaicism or somatic mutations in the reference population data. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R382C) has been classified as Uncertain significance.
Frequency
Consequence
NM_024642.5 missense
Scores
Clinical Significance
Conservation
Publications
- colorectal cancer, susceptibility to, 1Inheritance: AD Classification: LIMITED Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152174Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000239 AC: 6AN: 251486 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1461888Hom.: 0 Cov.: 33 AF XY: 0.0000234 AC XY: 17AN XY: 727248 show subpopulations
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152174Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74334 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
ClinVar
Submissions by phenotype
not provided Uncertain:2
This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 382 of the GALNT12 protein (p.Arg382His). This variant is present in population databases (no rsID available, gnomAD 0.007%). This missense change has been observed in individual(s) with colon cancer (PMID: 19617566). ClinVar contains an entry for this variant (Variation ID: 485662). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt GALNT12 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects GALNT12 function (PMID: 19617566). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
The GALNT12 c.1145G>A (p.Arg382His) variant has been reported in the published literature in individuals affected with colon cancer (PMID: 19617566 (2009)) and osteosarcoma (PMID: 32191290 (2020)). A functional study has indicated that this variant has virtually no enzyme transferase activity and the tumor showed loss of the wild type allele (PMID: 19617566 (2009)), however, further research is needed. The frequency of this variant in the general population, 0.000026 (3/113760 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Based on the available information, we are unable to determine the clinical significance of this variant. -
Colorectal cancer, susceptibility to, 1 Uncertain:2
- -
- -
not specified Uncertain:1
The p.R382H variant (also known as c.1145G>A), located in coding exon 6 of the GALNT12 gene, results from a G to A substitution at nucleotide position 1145. The arginine at codon 382 is replaced by histidine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. The evidence for this gene-disease relationship is limited; therefore, the clinical significance of this alteration is unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at